This dual mechanism produces both weight loss and glycemic control through direct appetite reductiona fundamentally different pathway than metformin
Results Later Period Baseline Demographic and Clinical Characteristics SGLT2i Cohort After applying all inclusion and exclusion criteria, the new-user cohort included 94,080 patients with a mean age of 73.1 (SD 8.9) years, of whom 47.0% were female, 56.1% were white, 46.0% had obesity, and 26.0% were current smokers (Table 1)
Costs can differ based on dosage, vendor, and whether the peptides are combined with other therapies, such as testosterone replacement, in research protocols
Most concerns about expired creatine are about whether it still works, not about safety if you use it as directed
Opportunity exists for therapies with better tolerability profiles, though it may be difficult for an agent to achieve both enhanced efficacy and tolerability
The clinical evidence base is substantial, and understanding it helps you contextualize what to reasonably expect - while keeping in mind that trial results reflect brand-name medications in controlled settings, not real-world outcomes from any specific compounded program